Expanded Access Study Of Palbociclib (PD-0332991) In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR-Positive, Her2-Negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate
Public ClinicalTrials.gov record NCT02142868. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
AN EXPANDED ACCESS STUDY OF PALBOCICLIB IN COMBINATION WITH LETROZOLE AS TREATMENT OF POST-MENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE, HER2 NEGATIVE ADVANCED BREAST CANCER FOR WHOM LETROZOLE THERAPY IS DEEMED APPROPRIATE
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To provide access to palbociclib to post-menopausal women with HR-positive, HER2-negative advanced breast cancer who are deemed appropriate for letrozole therapy (Canada: first-line patients only).
Study identification
- NCT ID
- NCT02142868
- Recruitment status
- No Longer Available
- Study type
- Expanded access
- Phase
- Not listed
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Dec 21, 2018
United States locations
- U.S. sites
- 44
- U.S. states
- 14
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| CBCC Global Research, Inc. at Comprehensive Blood & Cancer Center Research Center | Bakersfield | California | 93309 | — |
| MedStar Georgetown University Hospital | Washington D.C. | District of Columbia | 20007 | — |
| Washington Cancer Institute at MedStar Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | — |
| Gwinnett Hospital System Inc. -d/b/a - The Center for Cancer Care | Duluth | Georgia | 30096 | — |
| Gwinnett Hospital System Inc. -d/b/a - The Center for Cancer Care | Lawrenceville | Georgia | 30046 | — |
| Presence Saint Joseph Hospital | Chicago | Illinois | 60657 | — |
| North Shore Oncology-Hematology Associates, Ltd. | Crystal Lake | Illinois | 60014 | — |
| North Shore Oncology-Hematology Associates, Ltd. | Libertyville | Illinois | 60048 | — |
| Presence Medical Group Hematology Oncology | Northbrook | Illinois | 60062 | — |
| Illinois CancerCare, P.C. | Peoria | Illinois | 61615 | — |
| Presence Infusion Care - Skokie | Skokie | Illinois | 60077 | — |
| Metairie Oncologist, LLC | Metairie | Louisiana | 70006 | — |
| SKCCC at Johns Hopkins, The Harry and Jeannette Weinberg Building | Baltimore | Maryland | 21287 | — |
| SKCCC at Johns Hopkins, Green Spring Station | Lutherville | Maryland | 21093 | — |
| The West Clinic, P.C. | Corinth | Mississippi | 38834 | — |
| Jackson Oncology Associates, PLLC | Jackson | Mississippi | 39202 | — |
| Mississippi Baptist Health Systems | Jackson | Mississippi | 39202 | — |
| Jackson Oncology Associates, PLLC | Jackson | Mississippi | 39216 | — |
| The West Clinic, P.C. d/b/a West Cancer Center | Southaven | Mississippi | 38671 | — |
| ProHealthCARE Associates, LLP | Lake Success | New York | 11042 | — |
| Northwest Cancer Specialists dba Compass Oncology | Portland | Oregon | 97213 | — |
| Northwest Cancer Specialists dba Compass Oncology | Portland | Oregon | 97225 | — |
| UPMC Cancer Center Beaver | Beaver | Pennsylvania | 15009 | — |
| UPMC Cancer Center Arnold Palmer at Mountainview | Greensburg | Pennsylvania | 15601 | — |
| UPMC Cancer Center Greenville | Greenville | Pennsylvania | 16125 | — |
| UPMC Cancer Center Monroeville | Monroeville | Pennsylvania | 15146 | — |
| Magee-Womens Hospital of UPMC | Pittsburgh | Pennsylvania | 15213 | — |
| UPMC Cancer Center St. Margarets | Pittsburgh | Pennsylvania | 15215 | — |
| University of Pittsburgh Cancer Institute, Investigational Drug Service, William M. Cooper Pavilion | Pittsburgh | Pennsylvania | 15232 | — |
| University of Pittsburgh Medical Center, William M. Cooper Pavilion, Hillman Cancer Center | Pittsburgh | Pennsylvania | 15232 | — |
| UPMC Cancer Center Passavant (HOA) | Pittsburgh | Pennsylvania | 15237 | — |
| UPMC Cancer Center Passavant (OHA) | Pittsburgh | Pennsylvania | 15237 | — |
| UPMC Cancer Center Northwest | Seneca | Pennsylvania | 16346 | — |
| Mount Nittany Medical Center | State College | Pennsylvania | 16803 | — |
| The West Clinic, P.C. d/b/a West Cancer Center | Germantown | Tennessee | 38138 | — |
| The West Clinic, P.C. d/b/a West Cancer Center | Memphis | Tennessee | 38104 | — |
| The West Clinic, P.C. d/b/a West Cancer Center | Memphis | Tennessee | 38120 | — |
| Texas Oncology -Baylor Charles A. Sammons Cancer Center | Dallas | Texas | 75246 | — |
| Texas Oncology - Memorial City | Houston | Texas | 77024 | — |
| Medical Oncology & Hematology Associates of Northern Virginia, Ltd. | Fairfax | Virginia | 22031 | — |
| Medical Oncology & Hematology Associates of Northern Virginia, Ltd. | Reston | Virginia | 20190 | — |
| Swedish Cancer Institute | Seattle | Washington | 98104 | — |
| Northwest Cancer Specialists dba Compass Oncology | Vancouver | Washington | 98683 | — |
| Northwest Cancer Specialists dba Compass Oncology | Vancouver | Washington | 98684 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02142868, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 21, 2018 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02142868 live on ClinicalTrials.gov.